Medical specialists from Japan tagged as investigators in clinical trials studying Cholangitis
Total 15 results
-
Atsumasa KomoriSeen in:
- Nagasaki, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
- NCT04954859 (Principal Investigator)
-
Atsushi TanakaSeen in:
- Tokyo, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions: -
Fumihiko KusanoSeen in:
- Ibaraki, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
Conditions: -
Kazuhito KawataSeen in:
- Shizuoka, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions: -
Kazuo NotsumataSeen in:
- Fukui, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
-
Keiji TsujiSeen in:
- Hiroshima, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions: -
Koichi TakaguchiSeen in:
- Kagawa, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Kunihiko TsujiSeen in:
- Hokkaido, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions: -
Masanori AbeSeen in:
- Ehime, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions: -
Masanori AtsukawaSeen in:
- Tokyo, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Michio ImamuraSeen in:
- Hiroshima, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Mikio YanaseSeen in:
- Tokyo, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions: -
Tadashi NamisakiSeen in:
- Nara, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05630820 (Principal Investigator)
Conditions: -
Takeji UmemuraSeen in:
- Nagano, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Conditions: -
Tatehiro KagawaSeen in:
- Kanagawa, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Conditions:
Clinical Trials on Cholangitis
-
Medical University of WarsawNational Science Centre, PolandRecruitingPrimary Sclerosing Cholangitis (PSC)Poland
-
Mayo ClinicActive, not recruiting
-
Cascade Pharmaceuticals, IncCovanceCompletedPrimary Sclerosing Cholangitis (PSC)United States
-
Brigham and Women's HospitalCompletedSclerosing CholangitisUnited States
-
HighTide Biopharma Pty LtdCompletedPrimary Sclerosing Cholangitis (PSC)United States, Canada
-
Intercept PharmaceuticalsCompletedPrimary Sclerosing Cholangitis (PSC)United States, Italy
-
Mirum Pharmaceuticals, Inc.CompletedPrimary Sclerosing Cholangitis (PSC)United States, United Kingdom, Canada
-
Mayo ClinicCompletedPrimary Sclerosing Cholangitis (PSC)United States
-
RenJi HospitalRecruitingPrimary Sclerosing Cholangitis | IgG4-related Sclerosing CholangitisChina
-
Gilead SciencesCompletedPrimary Sclerosing Cholangitis (PSC)United States, Belgium, Canada, Germany, United Kingdom, Italy, Spain, Denmark, Netherlands, Sweden